Stay updated on Tralokinumab Combo in Japanese AD: Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.

Latest updates to the Tralokinumab Combo in Japanese AD: Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.0.2 and the Back to Top element was removed. No core content, pricing, stock, or time-slot information is affected.SummaryDifference0.2%
- Check10 days agoChange DetectedThe page has been updated to include a new publication from PubMed regarding the safety of tralokinumab in patients with moderate-to-severe atopic dermatitis, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference4%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations across various regions in Japan, as well as the introduction of new pharmaceutical terms and drug safety information. The previous version's specific city names and locations have been replaced with updated entries.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Tralokinumab Combo in Japanese AD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.